StonvexLoading…
StonvexCore line items from CLNE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $424.83M | $415.87M | $425.16M | $420.16M |
Operating Income | $-159.86M | $-36.35M | $-76.40M | $-51.71M |
Net Income | $-222.02M | $-83.07M | $-99.50M | $-58.73M |
EPS (Diluted) | $-1.01 | $-0.37 | $-0.45 | $-0.26 |
Total Assets | $1.06B | $1.24B | $1.26B | $1.08B |
Total Liabilities | $491.65M | $524.36M | $525.81M | $354.89M |
Cash & Equivalents | $155.58M | $89.51M | $104.94M | $123.95M |
Free Cash Flow OCF − CapEx | $59.85M | $-418.00K | $-57.16M | $22.21M |
Shares Outstanding | 219.33M | 223.46M | 223.03M | 222.44M |